Multimodality therapy for limited-stage small-cell lung cancer

Daniel Almquist, Kailash Mosalpuria, Apar Kishor Ganti

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations


Limited-stage small-cell lung cancer (SCLC) occurs in only one third of patients with SCLC, but it is potentially curable. Combined-modality therapy (chemotherapy and radiotherapy) has long been themainstay of therapy for this condition, butmore recent data suggest a role for surgery in early-stage disease. Prophylactic cranial irradiation seems to improve outcomes in patients who have responded to initial therapy. This review addresses the practical aspects of staging and treatment of patients with limited-stage SCLC.

Original languageEnglish (US)
Pages (from-to)111-117
Number of pages7
JournalJournal of oncology practice
Issue number2
StatePublished - Feb 2016

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)
  • Health Policy


Dive into the research topics of 'Multimodality therapy for limited-stage small-cell lung cancer'. Together they form a unique fingerprint.

Cite this